Rank:                    
Assistant Professor

Division:
               
Hematology & Oncology

Campus Address:
WTI 520A

Mailing Address:  
1720 2nd Avenue South, WTI 520B
Birmingham, AL 35294-3300

Phone:                   
(205) 996-9241


Departmental Affiliation(s):
Primary: Medicine, Hematology/Oncology


EDUCATION             

9/1981- 7/1986  M.D., Zhejiang University School of Medicine, China

8/1986- 12/1991 Residency training, Department of Obstetrics and Gynecology, 3rd Hospital of Ningbo and Hangzhou, Zhejiang, China

9/1993- 8/1994  Fellowship, Gynecologic Oncology, Women Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China     


Professional experience

5/1998-6/2006 Research Associate (II and III), Laboratory Manager, Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California at Los Angeles (Dr. Helena Chang)  
          
7/2006-7/2012   Assistant Research Scientist IV, Laboratory Manager, Gonda /UCLA Breast Cancer Research Laboratory, Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California at Los Angeles (Dr. Helena Chang)
                          
8/2012- 1/2014 Research Associate, Department of Pathology -Molecular & Cellular Pathology, University of Alabama at Birmingham (Dr. Ralph Sanderson)

3/2014- 3/2017   Researcher V, Laboratory Manager, Department of Medicine-Hematology & Oncology, University of Alabama at Birmingham (Dr. Ravi Bhatia)                          

4/2017- current   Assistant Professor, Laboratory Manager, Department of Medicine-Hematology & Oncology, University of Alabama at Birmingham (Dr. Ravi Bhatia)                                                                           


SELECTED PUBLICATIONS
  1. Ramani VCZhan F,  He JBarbieri PNoseda ATricot GSanderson RD. Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma. 2016 Jan 12;7(2):1598-607. PMID: 26624982
  2. Ping Z, Xia Y, Shen T, Parekh V, Siegal GP, Eltoum IE, He J, Chen D, Deng M, Xi R, Shen D. A microscopic landscape of the invasive breast cancer genome. Sci Rep. 2016; 6: 27545. PMID: 27283966
  3. Ping Z, Siegal GP, Harada S, Eltoum IE, Youssef M, Shen T, He J, Huang Y, Chen D, Li Y, Bland KI, Chang HR, Shen D. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast. Oncotarget. 2016 Dec 6; 7(49):80655-80663. PMID: 27811364
  4. Gibson CJ, Lindsley CR, Tchekmedyian V, Mar B, Shi J, Jaiswal S, Bosworth A, Francisco LF, He J, Morgan E, Lacasce A, Koreth J, Ho V, Soiffer R, Antin J, Ritz J, Nikiforow S, Forman SJ, Michor F, Neuberg D, Bhatia R, Bhatia S, Ebert B L. Clonal hematopoiesis associated with adverse outcomes following autologous stem cell transplantation for lymphoma. J Clin Oncol. 2017 May 10;35(14):1598-1605. PMID: 28068180


Publications: See a listing of publications on PubMed , a service of the National Library of Medicine.